Title:
経口的に生物学的に利用可能な脂質ベースの構築物
Document Type and Number:
Japanese Patent JP2010540559
Kind Code:
A
Abstract:
The present invention is embodied by a composition capable of chaperoning a typically non-orally available therapeutic or diagnostic agent through the environment of the digestive tract such that the therapeutic or diagnostic agent is bioavailable. The composition may or may not be targeted to specific cellular receptors, such as hepatocytes. Therapeutic agents include, but are not limited to, insulin, calcitonin, serotonin, and other proteins. Targeting is accomplished with biotin or metal based targeting agents.
More Like This:
| JP2020073601 | TREATMENT OF BREAST CANCER WITH LIPOSOMAL IRINOTECAN |
| WO/1997/025339 | COMPOSITION AND METHOD FOR DELIVERY OF NUCLEIC ACIDS |
| WO/2016/163443 | CONTAINER FOR BUBBLE PRODUCTION |
Inventors:
Lowe, Jiyoung Earl
Double, Blair, Geo
Double, Blair, Geo
Application Number:
JP2010527213A
Publication Date:
December 24, 2010
Filing Date:
September 26, 2008
Export Citation:
Assignee:
Sdaisy Incorporated
International Classes:
A61K9/127; A61K31/198; A61K31/4045; A61K38/21; A61K38/23; A61K38/26; A61K38/28; A61K39/395; A61K47/02; A61K47/18; A61K47/22; A61K47/24; A61K47/26; A61K47/28; A61K47/42; A61P3/10
Domestic Patent References:
| JPH04500803A | 1992-02-13 | |||
| JPH04500803A | 1992-02-13 |
Foreign References:
| WO2006127361A2 | 2006-11-30 |
Attorney, Agent or Firm:
Patent business corporation Odashima patent office